Mingying Li Selected Research

Mingying Li Research Topics

Disease

13	Neoplasms (Cancer) 11/2023 - 02/2007
4	Lung Neoplasms (Lung Cancer) 03/2014 - 02/2007
3	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2023 - 01/2021
3	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2022 - 03/2014
2	Leukemia 01/2023 - 01/2021
2	Infections 01/2019 - 01/2018
2	Inflammation (Inflammations) 01/2019 - 12/2014
2	Testicular Neoplasms (Testicular Cancer) 03/2014 - 02/2007
1	Umbilical Hernia (Omphalocele) 02/2024
1	Fibrosis (Cirrhosis) 02/2024
1	Postoperative Nausea and Vomiting (PONV) 02/2024
1	Hernia (Hernias) 02/2024
1	Pain (Aches) 02/2024
1	Azoospermia 01/2023
1	Breast Neoplasms (Breast Cancer) 01/2023
1	Postoperative Cognitive Complications 01/2023
1	Pathologic Complete Response 01/2023
1	Optic Atrophy 01/2023
1	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 01/2023
1	Precursor T-Cell Lymphoblastic Leukemia-Lymphoma (T-ALL) 01/2023
1	Cognitive Dysfunction 01/2023
1	Adenocarcinoma of Lung 01/2022
1	Colorectal Neoplasms (Colorectal Cancer) 10/2021
1	Abdominal Obesity 11/2019
1	Metabolic Syndrome (Dysmetabolic Syndrome X) 11/2019
1	Tuberculosis (Tuberculoses) 01/2018
1	Pleural Effusion (Pleural Effusions) 07/2014
1	Malignant Pleural Effusion 07/2014
1	Adenocarcinoma 01/2014
1	Pneumonia (Pneumonitis) 01/2014
1	Squamous Cell Carcinoma (Epidermoid Carcinoma) 01/2014
1	Neoplasm Metastasis (Metastasis) 05/2012
1	Hepatocellular Carcinoma (Hepatoma) 01/2012
1	Brain Neoplasms (Brain Tumor) 02/2007

Drug/Important Bio-Agent (IBA)

7	Proteins (Proteins, Gene)FDA Link 11/2023 - 02/2007
5	Biomarkers (Surrogate Marker)IBA 01/2023 - 07/2014
3	Messenger RNA (mRNA)IBA 01/2023 - 02/2007
3	CytokinesIBA 01/2019 - 10/2017
2	6-methyladenineIBA 01/2023 - 10/2021
2	N-methyladenosineIBA 01/2023 - 10/2021
2	EnzymesIBA 01/2022 - 10/2021
2	Long Noncoding RNAIBA 01/2022 - 01/2022
2	RNA (Ribonucleic Acid)IBA 01/2022 - 10/2021
2	matrigelIBA 01/2019 - 05/2012
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2019 - 07/2014
2	Tyrosine (L-Tyrosine)FDA Link 03/2014 - 02/2007
2	AntigensIBA 03/2014 - 02/2007
2	CalciumIBA 03/2014 - 02/2007
1	S-demethylaseIBA 01/2023
1	interferon regulatory factor-8 (interferon consensus sequence binding protein)IBA 01/2023
1	luteolin-7-glucosideIBA 01/2023
1	Sevoflurane (Ultane)FDA LinkGeneric 01/2023
1	Adenosine Triphosphate (ATP)IBA 01/2023
1	FlavonoidsIBA 01/2023
1	Transcription Factors (Transcription Factor)IBA 01/2023
1	AnthracyclinesIBA 01/2023
1	Tissue Kallikreins (Tissue Kallikrein)IBA 01/2023
1	Dynamins (Dynamin)IBA 01/2023
1	Serine Proteases (Serine Protease)IBA 01/2023
1	Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA 01/2023
1	ErbB Receptors (EGF Receptor)IBA 01/2023
1	MethyltransferasesIBA 11/2022
1	Fatty Acids (Saturated Fatty Acids)IBA 01/2022
1	CeramidesIBA 10/2021
1	Triglycerides (Triacylglycerol)IBA 11/2019
1	oxidized low density lipoproteinIBA 11/2019
1	InterleukinsIBA 01/2019
1	Phosphotransferases (Kinase)IBA 01/2019
1	Nitric Oxide (Nitrogen Monoxide)FDA Link 01/2019
1	Nitric Oxide Synthase Type II (Inducible Nitric Oxide Synthase)IBA 01/2019
1	MicroRNAs (MicroRNA)IBA 01/2018
1	Toll-Like Receptors (Toll-Like Receptor)IBA 10/2017
1	Toll-Like Receptor 3IBA 10/2017
1	Oncogene Proteins (Oncogene Protein)IBA 10/2017
1	CurcuminIBA 12/2014
1	Adenosine DeaminaseIBA 07/2014
1	Interleukin-10 (Interleukin 10)IBA 07/2014
1	Interferon-gamma (Interferon, gamma)IBA 07/2014
1	Small Interfering RNA (siRNA)IBA 03/2014
1	Protein Isoforms (Isoforms)IBA 03/2014
1	IodineIBA 01/2014
1	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 05/2012
1	U 0126 (UO 126)IBA 05/2012
1	Calcium-Binding ProteinsIBA 01/2009
1	AntibodiesIBA 02/2007
1	Immunoglobulin G (IgG)IBA 02/2007

Therapy/Procedure

4	Immunotherapy 01/2023 - 02/2007
2	Anesthesia 02/2024 - 01/2023
2	Drug Therapy (Chemotherapy) 01/2023 - 01/2021
2	Therapeutics 01/2023 - 05/2012
1	Analgesia 02/2024
1	Induction Chemotherapy 01/2023
1	Aftercare (After-Treatment) 01/2022
1	Radiofrequency Ablation 01/2012